Phytosterols are one of the few winners in EFSA's latest round of health claims opinions.
Among the many rejections of Article 13.1 claims published by the European Food Safety Authority (EFSA; Parma, Italy) on October 19, there were some notable winners-one being plant sterols and stanols.
EFSA’s Panel on Dietetic Products, Nutrition, and Allergies (NDA) confirmed a cause and effect relationship between plant sterols and stanols and blood cholesterol reduction. The NDA panel stated that wording claims like “Plant sterols/stanols help to maintain normal blood cholesterol levels,” and “Plant sterols/stanols contribute to the maintenance of normal blood cholesterol levels” are supported by the scientific evidence that was provided to the panel.
In order to validate the use of such claims, the panel decided on a minimum required content of 0.8 g of sterols/stanols per serving of a food.
The panel also warned that consumption of the ingredients might not be nutritionally appropriate for pregnant or breastfeeding women and children under five years old.
To download EFSA’s full document on plant sterols and stanols, click here.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.
U.S. Hemp Authority announces Adult Use Hemp Product Certification Program
April 15th 2024The U.S. Hemp Authority (USHA) has announced the launch of its Adult Use Hemp Product Certification Program in an effort to “reshape public policy around hemp, and to build confidence among retailers and consumers alike.”